1. Novel urine biomarkers to distinguish UTI from culture-negative pyuria
- Author
-
Hill, Elaise B., Watson, Joshua R., Cohen, Daniel M., Kline, David, Schwaderer, Andrew L., and Spencer, John D.
- Subjects
Urinary tract infections -- Diagnosis -- Risk factors ,Children -- Diseases ,Urinary tract infections in children -- Diagnosis -- Risk factors ,Health - Abstract
Background Emergency departments (EDs) often rely on urinalysis (UA) to rapidly identify urinary tract infections (UTIs) in children. However, the suboptimal test characteristics of UA can lead to false-positive results. Novel urinary biomarkers may increase the diagnostic precision of UA. In this study, we compared the concentrations of 6 pre-selected proteins: BH3 interacting domain death agonist (BID), B-cell lymphoma 6 protein, ras GTPase-activating protein 1, cathepsin S (CTSS), 3-hydroxyanthranilate 3,4-dioxygenase, and transgelin-2. Methods In a pediatric ED, we prospectively enrolled 167 children with UA and urine culture collected. Pyuria was defined as either [greater than or equal to] 5 white blood cells per high-power field on microscopy or positive leukocyte esterase (LE). The urine culture was considered positive if it yielded [greater than or equal to] 50,000 colony-forming units per milliliter of any single urinary pathogen. Urine protein levels were measured by enzyme-linked immunosorbent assay and normalized to urine creatinine. Results BID was significantly higher in the UTI group compared to the culture-negative pyuria group with a mean ratio of 1.42 (95% confidence interval (CI), 1.15, 1.76) when uncorrected for creatinine concentration. When corrected for creatinine concentration, CTSS was significantly elevated in the UTI group compared to the culture-negative pyuria group with a mean ratio of 2.11 (95% CI, 1.39, 3.21). Conclusions BID and CTSS concentrations were elevated in the urine of children with UTI compared to those with culture-negative pyuria. These proteins deserve further research into their utility to serve as novel biomarkers for UTI. Graphical abstract, Author(s): Elaise B Hill [sup.1] [sup.2] , Joshua R Watson [sup.3] , Daniel M Cohen [sup.1] , David Kline [sup.4] , Andrew L Schwaderer [sup.5] , John D Spencer [sup.6] [...]
- Published
- 2022
- Full Text
- View/download PDF